Thermo Fisher (TMO) Director Jennifer M. Johnson Receives Award

What Happened Jennifer M. Johnson, a director of Thermo Fisher Scientific (TMO), was credited with 46.3 deferred stock units on September 26, 2026 as an award under the Issuer's Deferred Compensation Plan for Directors. The units were priced at $675.00 each, representing a notional value of $31,252.50. These are derivative units convertible into common stock on a 1-for-1 basis and are distributable as shares upon cessation of director service or a change of control.

Key Details

• Transaction date: 2026-09-26; Form 4 filed: 2026-09-29.
• Award type: Grant/award (derivative stock units) — 46.3 units at $675.00 per unit.
• Approximate notional value: $31,252.50.
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 — units convertible 1-for-1 into Common Stock. F2 — units credited under the directors' Deferred Compensation Plan; retainers deferred quarterly and converted to stock units based on quarter-end closing price; distributable upon cessation of service or change of control.
• Remarks: Reporting person is CEO and a Director of Franklin Resources Inc.; she disclaims beneficial ownership of any Thermo Fisher shares held by Franklin Templeton-managed funds.

Context Deferred stock units awarded to directors are routine compensation and do not represent an open-market purchase or sale. These units are a form of deferred pay that convert to actual shares only under specified conditions (e.g., leaving the board or a change of control), so they are not an immediate bullish or bearish trading signal.